Tepoxalin
From Self-sufficiency
| File:Tepoxalin.png | |
| Systematic (IUPAC) name | |
|---|---|
|
3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ATCvet code | QM01AE92 (WHO) |
| PubChem | CID 59757 |
| Chemical data | |
| Formula | C20H20ClN3O3 |
| Molar mass | 385.844 g/mol[[Script error: No such module "String".]] |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use (in dogs) in the United States and the European Union. It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.
It is generally marketed under the brand name Zubrin.
References
| 40x30px | This veterinary medicine–related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Missing redirects
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Dog health
- Pyrazoles
- Hydroxamic acids
- Non-steroidal anti-inflammatory drugs
- Phenol ethers
- Organochlorides
- Veterinary medicine stubs
- 2Fix
